No Data
No Data
Coya Therapeutics Chairman and CEO Howard Berman Selected for PharmaVoice 100
Coya Therapeutics to Participate in Fireside Chat at the Chardan 8th Annual Genetic Medicines Conference
This Yelp Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
Express News | Coya Therapeutics Announces Subcutaneously Administered Coya 302 Elicits Direct Anti-Inflammatory Effect in Brain in a Preclinical Inflammatory Mouse Model of Parkinson’s Disease
Coya Therapeutics Analyst Ratings
H.C. Wainwright Initiates Coya Therapeutics(COYA.US) With Buy Rating, Announces Target Price $18
No Data
No Data